Celldex Therapeutics
CLDX
#4701
Rank
$1.95 B
Marketcap
$29.45
Share price
-0.51%
Change (1 day)
13.01%
Change (1 year)

Market capitalization of Celldex Therapeutics (CLDX)

Market cap: $1.95 Billion USD

As of December 2025 Celldex Therapeutics has a market cap of $1.95 Billion USD. This makes Celldex Therapeutics the world's 4701th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celldex Therapeutics from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025$1.95 B16.17%
2024$1.68 B-22.34%
2023$2.16 B3.32%
2022$2.09 B16.26%
2021$1.80 B160.23%
2020$0.69 B1733.29%
2019$37.84 M6.63%
2018$35.49 M-90.81%
2017$0.38 B7.75%
2016$0.35 B-76.84%
2015$1.54 B-5.36%
2014$1.63 B-24.33%
2013$2.16 B400.33%
2012$0.43 B276.23%
2011$0.11 B-13.09%
2010$0.13 B-10.75%
2009$0.14 B18.32%
2008$0.12 B237.13%
2007$37.09 M-62.96%
2006$0.10 B-28.18%
2005$0.13 B-6.42%
2004$0.14 B-15.96%
2003$0.17 B158.92%
2002$68.47 M-71.75%
2001$0.24 B-38.3%
2000$0.39 B230.62%
1999$0.11 B59.73%
1998$74.39 M15.24%
1997$64.55 M99.57%
1996$32.34 M

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Celldex Therapeutics was reported to be:

$1.95 Billion USD
by Nasdaq info icon info icon
$1.95 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
$43.15 B 2,105.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$0.13 B-93.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.63 B-67.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$177.63 B 8,977.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$147.99 B 7,462.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$97.71 B 4,893.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
$6.13 M-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA